Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1332328

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1332328

Cell Analysis

PUBLISHED:
PAGES: 83 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cell Analysis Market to Reach $34.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Cell Analysis estimated at US$27.3 Billion in the year 2022, is projected to reach a revised size of US$34.1 Billion by 2030, growing at aCAGR of 2.8% over the period 2022-2030. Flow Cytometry Products, one of the segments analyzed in the report, is projected to record 3.6% CAGR and reach US$10.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the qPCR Products segment is readjusted to a revised 3.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.4 Billion, While China is Forecast to Grow at 7.2% CAGR

The Cell Analysis market in the U.S. is estimated at US$7.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$8 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -1% and 1.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -0.2% CAGR.

Select Competitors (Total 21 Featured) -

  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biostatus Limited
  • Carl Zeiss
  • Cell Biolabs, Inc
  • Creative Bioarray
  • Cytek Biosciences
  • Danaher
  • GE Healthcare (A Subsidiary of General Electric Company)
  • Meiji Techno
  • Merck KGaA
  • Miltenyi Biotec
  • Nanocellect Biomedical
  • Olympus Corporation
  • Perkinelmer
  • Promega Corporation
  • Sysmex Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific
Show more
Product Code: MCP21450

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Cell Analysis - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Flow Cytometry Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Flow Cytometry Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Flow Cytometry Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for qPCR Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for qPCR Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for qPCR Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cell Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cell Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cell Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Microscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Microscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Microscopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Spectrophotometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Spectrophotometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Spectrophotometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cell Counters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cell Counters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cell Counters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies and CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Pharma & Biotech Companies and CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Pharma & Biotech Companies and CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 37: World Cell Analysis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • JAPAN
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • CHINA
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • EUROPE
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cell Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cell Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • FRANCE
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: France 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • GERMANY
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Cell Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Cell Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • INDIA
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: India 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: India 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Cell Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Cell Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Cell Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Cell Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030
  • AFRICA
    • Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Cell Analysis by Product - Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Cell Analysis by Product - Percentage Breakdown of Value Sales for Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters and Other Products for the Years 2014, 2023 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Cell Analysis by End-Use - Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Other End-Uses, Pharma & Biotech Companies and CROs and Hospitals & Diagnostic Laboratories for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!